Cargando…
Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis
BACKGROUND: Lipids may influence cellular penetrance by viral pathogens and the immune response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 and compared that with infection with other pathogens in patients admitted with acute respiratory distress syndrome to an intensi...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637636/ https://www.ncbi.nlm.nih.gov/pubmed/37948331 http://dx.doi.org/10.1002/ctm2.1440 |
_version_ | 1785133442491482112 |
---|---|
author | Meng, Hu Sengupta, Arjun Ricciotti, Emanuela Mrčela, Antonijo Mathew, Divij Mazaleuskaya, Liudmila L. Ghosh, Soumita Brooks, Thomas G. Turner, Alexandra P. Schanoski, Alessa Soares Lahens, Nicholas F. Tan, Ai Wen Woolfork, Ashley Grant, Greg Susztak, Katalin Letizia, Andrew G. Sealfon, Stuart C. Wherry, E. John Laudanski, Krzysztof Weljie, Aalim M. Meyer, Nuala J. FitzGerald, Garret A. |
author_facet | Meng, Hu Sengupta, Arjun Ricciotti, Emanuela Mrčela, Antonijo Mathew, Divij Mazaleuskaya, Liudmila L. Ghosh, Soumita Brooks, Thomas G. Turner, Alexandra P. Schanoski, Alessa Soares Lahens, Nicholas F. Tan, Ai Wen Woolfork, Ashley Grant, Greg Susztak, Katalin Letizia, Andrew G. Sealfon, Stuart C. Wherry, E. John Laudanski, Krzysztof Weljie, Aalim M. Meyer, Nuala J. FitzGerald, Garret A. |
author_sort | Meng, Hu |
collection | PubMed |
description | BACKGROUND: Lipids may influence cellular penetrance by viral pathogens and the immune response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 and compared that with infection with other pathogens in patients admitted with acute respiratory distress syndrome to an intensive care unit (ICU). METHODS: Mass spectrometry was used to characterise lipids and relate them to proteins, peripheral cell immunotypes and disease severity. RESULTS: Circulating phospholipases (sPLA2, cPLA2 (PLA2G4A) and PLA2G2D) were elevated on admission in all ICU groups. Cyclooxygenase, lipoxygenase and epoxygenase products of arachidonic acid (AA) were elevated in all ICU groups compared with controls. sPLA2 predicted severity in COVID‐19 and correlated with TxA2, LTE4 and the isoprostane, iPF2α‐III, while PLA2G2D correlated with LTE4. The elevation in PGD2, like PGI2 and 12‐HETE, exhibited relative specificity for COVID‐19 and correlated with sPLA2 and the interleukin‐13 receptor to drive lymphopenia, a marker of disease severity. Pro‐inflammatory eicosanoids remained correlated with severity in COVID‐19 28 days after admission. Amongst non‐COVID ICU patients, elevations in 5‐ and 15‐HETE and 9‐ and 13‐HODE reflected viral rather than bacterial disease. Linoleic acid (LA) binds directly to SARS‐CoV‐2 and both LA and its di‐HOME products reflected disease severity in COVID‐19. In healthy marines, these lipids rose with seroconversion. Eicosanoids linked variably to the peripheral cellular immune response. PGE2, TxA2 and LTE4 correlated with T cell activation, as did PGD2 with non‐B non‐T cell activation. In COVID‐19, LPS stimulated peripheral blood mononuclear cell PGF2α correlated with memory T cells, dendritic and NK cells while LA and DiHOMEs correlated with exhausted T cells. Three high abundance lipids – ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 – were altered specifically in COVID. LPC‐O‐16:0 was strongly correlated with T helper follicular cell activation and all three negatively correlated with multi‐omic inflammatory pathways and disease severity. CONCLUSIONS: A broad based lipidomic storm is a predictor of poor prognosis in ARDS. Alterations in sPLA2, PGD2 and 12‐HETE and the high abundance lipids, ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 exhibit relative specificity for COVID‐19 amongst such patients and correlate with the inflammatory response to link to disease severity. |
format | Online Article Text |
id | pubmed-10637636 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-106376362023-11-11 Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis Meng, Hu Sengupta, Arjun Ricciotti, Emanuela Mrčela, Antonijo Mathew, Divij Mazaleuskaya, Liudmila L. Ghosh, Soumita Brooks, Thomas G. Turner, Alexandra P. Schanoski, Alessa Soares Lahens, Nicholas F. Tan, Ai Wen Woolfork, Ashley Grant, Greg Susztak, Katalin Letizia, Andrew G. Sealfon, Stuart C. Wherry, E. John Laudanski, Krzysztof Weljie, Aalim M. Meyer, Nuala J. FitzGerald, Garret A. Clin Transl Med Research Articles BACKGROUND: Lipids may influence cellular penetrance by viral pathogens and the immune response that they evoke. We deeply phenotyped the lipidomic response to SARs‐CoV‐2 and compared that with infection with other pathogens in patients admitted with acute respiratory distress syndrome to an intensive care unit (ICU). METHODS: Mass spectrometry was used to characterise lipids and relate them to proteins, peripheral cell immunotypes and disease severity. RESULTS: Circulating phospholipases (sPLA2, cPLA2 (PLA2G4A) and PLA2G2D) were elevated on admission in all ICU groups. Cyclooxygenase, lipoxygenase and epoxygenase products of arachidonic acid (AA) were elevated in all ICU groups compared with controls. sPLA2 predicted severity in COVID‐19 and correlated with TxA2, LTE4 and the isoprostane, iPF2α‐III, while PLA2G2D correlated with LTE4. The elevation in PGD2, like PGI2 and 12‐HETE, exhibited relative specificity for COVID‐19 and correlated with sPLA2 and the interleukin‐13 receptor to drive lymphopenia, a marker of disease severity. Pro‐inflammatory eicosanoids remained correlated with severity in COVID‐19 28 days after admission. Amongst non‐COVID ICU patients, elevations in 5‐ and 15‐HETE and 9‐ and 13‐HODE reflected viral rather than bacterial disease. Linoleic acid (LA) binds directly to SARS‐CoV‐2 and both LA and its di‐HOME products reflected disease severity in COVID‐19. In healthy marines, these lipids rose with seroconversion. Eicosanoids linked variably to the peripheral cellular immune response. PGE2, TxA2 and LTE4 correlated with T cell activation, as did PGD2 with non‐B non‐T cell activation. In COVID‐19, LPS stimulated peripheral blood mononuclear cell PGF2α correlated with memory T cells, dendritic and NK cells while LA and DiHOMEs correlated with exhausted T cells. Three high abundance lipids – ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 – were altered specifically in COVID. LPC‐O‐16:0 was strongly correlated with T helper follicular cell activation and all three negatively correlated with multi‐omic inflammatory pathways and disease severity. CONCLUSIONS: A broad based lipidomic storm is a predictor of poor prognosis in ARDS. Alterations in sPLA2, PGD2 and 12‐HETE and the high abundance lipids, ChoE 18:3, LPC‐O‐16:0 and PC‐O‐30:0 exhibit relative specificity for COVID‐19 amongst such patients and correlate with the inflammatory response to link to disease severity. John Wiley and Sons Inc. 2023-11-10 /pmc/articles/PMC10637636/ /pubmed/37948331 http://dx.doi.org/10.1002/ctm2.1440 Text en © 2023 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Meng, Hu Sengupta, Arjun Ricciotti, Emanuela Mrčela, Antonijo Mathew, Divij Mazaleuskaya, Liudmila L. Ghosh, Soumita Brooks, Thomas G. Turner, Alexandra P. Schanoski, Alessa Soares Lahens, Nicholas F. Tan, Ai Wen Woolfork, Ashley Grant, Greg Susztak, Katalin Letizia, Andrew G. Sealfon, Stuart C. Wherry, E. John Laudanski, Krzysztof Weljie, Aalim M. Meyer, Nuala J. FitzGerald, Garret A. Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title | Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title_full | Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title_fullStr | Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title_full_unstemmed | Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title_short | Deep phenotyping of the lipidomic response in COVID‐19 and non‐COVID‐19 sepsis |
title_sort | deep phenotyping of the lipidomic response in covid‐19 and non‐covid‐19 sepsis |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637636/ https://www.ncbi.nlm.nih.gov/pubmed/37948331 http://dx.doi.org/10.1002/ctm2.1440 |
work_keys_str_mv | AT menghu deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT senguptaarjun deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT ricciottiemanuela deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT mrcelaantonijo deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT mathewdivij deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT mazaleuskayaliudmilal deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT ghoshsoumita deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT brooksthomasg deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT turneralexandrap deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT schanoskialessasoares deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT lahensnicholasf deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT tanaiwen deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT woolforkashley deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT grantgreg deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT susztakkatalin deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT letiziaandrewg deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT sealfonstuartc deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT wherryejohn deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT laudanskikrzysztof deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT weljieaalimm deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT meyernualaj deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis AT fitzgeraldgarreta deepphenotypingofthelipidomicresponseincovid19andnoncovid19sepsis |